Pentoxifylline in human immunodeficiency virus-positive tuberculosis: Safety at 4 years [2]

R. S. Wallis, J. L. Johnson, A. Okwera, P. Nsubuga, C. C. Whalen, R. D. Mugerwa, J. J. Ellner

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1861
Number of pages1
JournalJournal of Infectious Diseases
Volume178
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

AIDS-Related Opportunistic Infections
Pentoxifylline
Pulmonary Tuberculosis
HIV Infections
Tuberculosis
Tumor Necrosis Factor-alpha
HIV
Safety
Recurrence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Wallis, R. S., Johnson, J. L., Okwera, A., Nsubuga, P., Whalen, C. C., Mugerwa, R. D., & Ellner, J. J. (1998). Pentoxifylline in human immunodeficiency virus-positive tuberculosis: Safety at 4 years [2]. Journal of Infectious Diseases, 178(6), 1861. https://doi.org/10.1086/314528

Pentoxifylline in human immunodeficiency virus-positive tuberculosis : Safety at 4 years [2]. / Wallis, R. S.; Johnson, J. L.; Okwera, A.; Nsubuga, P.; Whalen, C. C.; Mugerwa, R. D.; Ellner, J. J.

In: Journal of Infectious Diseases, Vol. 178, No. 6, 1998, p. 1861.

Research output: Contribution to journalArticle

Wallis, RS, Johnson, JL, Okwera, A, Nsubuga, P, Whalen, CC, Mugerwa, RD & Ellner, JJ 1998, 'Pentoxifylline in human immunodeficiency virus-positive tuberculosis: Safety at 4 years [2]', Journal of Infectious Diseases, vol. 178, no. 6, pp. 1861. https://doi.org/10.1086/314528
Wallis, R. S. ; Johnson, J. L. ; Okwera, A. ; Nsubuga, P. ; Whalen, C. C. ; Mugerwa, R. D. ; Ellner, J. J. / Pentoxifylline in human immunodeficiency virus-positive tuberculosis : Safety at 4 years [2]. In: Journal of Infectious Diseases. 1998 ; Vol. 178, No. 6. pp. 1861.
@article{f8e001d6a77946bebb07d4e31694c2ca,
title = "Pentoxifylline in human immunodeficiency virus-positive tuberculosis: Safety at 4 years [2]",
author = "Wallis, {R. S.} and Johnson, {J. L.} and A. Okwera and P. Nsubuga and Whalen, {C. C.} and Mugerwa, {R. D.} and Ellner, {J. J.}",
year = "1998",
doi = "10.1086/314528",
language = "English (US)",
volume = "178",
pages = "1861",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Pentoxifylline in human immunodeficiency virus-positive tuberculosis

T2 - Safety at 4 years [2]

AU - Wallis, R. S.

AU - Johnson, J. L.

AU - Okwera, A.

AU - Nsubuga, P.

AU - Whalen, C. C.

AU - Mugerwa, R. D.

AU - Ellner, J. J.

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=18144452241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144452241&partnerID=8YFLogxK

U2 - 10.1086/314528

DO - 10.1086/314528

M3 - Article

C2 - 9815253

AN - SCOPUS:18144452241

VL - 178

SP - 1861

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -